Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Blocking cell death in hair follicles can lead to impaired hair growth.

CD34 marks potential stem cells in dog hair follicles.

PDGF isoforms can promote and sustain hair growth.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Benign follicular mucinosis involves immune cells attacking hair follicles.

CXCR2 in skin cells promotes tumor growth.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

cDermo-1 causes dense skin, feathers, and scales in chickens.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Basal cell carcinoma behaves like hair follicles and targeting specific pathways may help treat it.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

ILC1-like cells can independently cause alopecia areata.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Langerhans' cells are not responsible for depigmentation in this mouse model.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.